These results suggest that the prophylactic targeting of AKT2 impairs the seeding of invasive cells in the metastatic niche, fully preventing metastatic formation rather than restraining the growth of dormant but intact metastatic tumor cells. The gene discussed is AKT2; the disease is neoplasm.